Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.

PNNL celebrates World Energy Storage Day (September 22) by introducing you to some of our best and brightest in this area.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.

The Rapid Assessment of Platform Technologies to Expedite Response project aims to prepare against future pandemics.

PNNL welcomes six Department of Energy Office of Science Graduate Student Research awardees from across the nation.

PNNL’s wide-ranging report maps the current nanobiotechnology landscape, flags potential concerns, and details the need for an organizing body to coordinate currently disparate disciplines.

A new flow battery design achieves long life and capacity for grid energy storage from renewable fuels.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

Lauren Charles, a chief data scientist at PNNL, joined the editorial board of the largest open access journal published by Nature Research.

Joshua Adkins and Jamie Lo will lead PMedIC, Pacific Northwest National Laboratory and Oregon Health & Science University’s joint research institute.

COVID-19 infections at PNNL early in the pandemic were caused by a wide variety of viral sequences, according to a new analysis by Laboratory researchers.

PNNL battery researcher Jie Xiao collaborates with academic and industry partners to address scientific challenges in manufacturing lithium-based batteries.

Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

PNNL researchers design liquid-based porous electrolyte that could transport lithium ions more easily between electrodes, improving battery efficiency.

Exploring why some brains are more resilient to the impact of Alzheimer’s disease could lead to improved diagnoses, treatment and prevention.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.